Researchers at the Nanoscience Initiative at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made a breakthrough in the fight against viral diseases.
Targeting viral envelope glycans offers promising path toward world’s first broad-spectrum antiviral
